Related Experiment Video
Updated: May 9, 2026

11:56
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Modeling the regional spread and control of vancomycin-resistant enterococci
Bruce Y Lee1, S Levent Yilmaz, Kim F Wong
1Public Health Computational and Operations Research, University of Pittsburgh, Pittsburgh, PA 15213, USA. BYL1@pitt.edu
American Journal of Infection Control
|July 31, 2013
Summary
Vancomycin-resistant enterococci (VRE) can spread between hospitals. A 10% increase in VRE colonization in one hospital can increase prevalence in others by 2.8% over several years.
Area of Science:
- Healthcare epidemiology
- Infectious disease transmission
- Computational modeling
Background:
- Patients can carry vancomycin-resistant enterococci (VRE) for extended periods.
- VRE poses a risk for transmission between healthcare facilities.
Purpose of the Study:
- To quantify the impact of VRE colonization prevalence changes in one hospital on other hospitals within a region.
- To assess the speed at which these regional effects manifest.
Main Methods:
- Utilized the Regional Healthcare Ecosystem Analyst, an agent-based model.
- Simulated patient flow across all hospitals and communities in Orange County, California.
- Quantified VRE prevalence changes and their spread.
Main Results:
- A sustained 10% increase in VRE colonization prevalence in one hospital led to an average 2.8% relative increase in other hospitals.
- The full impact of these changes took 1.5 to over 10 years to materialize.
- Larger hospitals demonstrated a more significant influence on VRE prevalence in other facilities.
Conclusions:
- Regional VRE transmission dynamics are significant and should be considered in surveillance and control strategies.
- Understanding inter-facility patient sharing is crucial for designing effective VRE containment programs.
- Targeting specific hospitals based on their connectivity can optimize VRE control efforts.
Keywords:
Health care-associated infectionsHospitalsModelingSimulationVancomycin-resistant EnterococcusMore Related Videos
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...

